Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction: The HeartStrong Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Importance: Adherence to medications prescribed after acute myocardial infarction (AMI) is low. Wireless technology and behavioral economic approaches have shown promise in improving health behaviors. Objective: To determine whether a system of medication reminders using financial incentives and social support delays subsequent vascular events in patients following AMI compared with usual care. Design, Setting, and Participants: Two-arm, randomized clinical trial with a 12-month intervention conducted from 2013 through 2016. Investigators were blinded to study group, but participants were not. Design was a health plan-intermediated intervention for members of several health plans. We recruited 1509 participants from 7179 contacted AMI survivors (insured with 5 large US insurers nationally or with Medicare fee-for-service at the University of Pennsylvania Health System). Patients aged 18 to 80 years were eligible if currently prescribed at least 2 of 4 study medications (statin, aspirin, β-blocker, antiplatelet agent), and were hospital inpatients for 1 to 180 days and discharged home with a principal diagnosis of AMI. Interventions: Patients were randomized 2:1 to an intervention using electronic pill bottles combined with lottery incentives and social support for medication adherence (1003 patients), or to usual care (506 patients). Main Outcomes and Measures: Primary outcome was time to first vascular rehospitalization or death. Secondary outcomes were time to first all-cause rehospitalization, total number of repeated hospitalizations, medication adherence, and total medical costs. Results: A total of 35.5% of participants were female (n = 536); mean (SD) age was 61.0 (10.3) years. There were no statistically significant differences between study arms in time to first rehospitalization for a vascular event or death (hazard ratio, 1.04; 95% CI, 0.71 to 1.52; P = .84), time to first all-cause rehospitalization (hazard ratio, 0.89; 95% CI, 0.73 to 1.09; P = .27), or total number of repeated hospitalizations (hazard ratio, 0.94; 95% CI, 0.60 to 1.48; P = .79). Mean (SD) medication adherence did not differ between control (0.42 [0.39]) and intervention (0.46 [0.39]) (difference, 0.04; 95% CI, -0.01 to 0.09; P = .10). Mean (SD) medical costs in 12 months following enrollment did not differ between control ($29 811 [$74 850]) and intervention ($24 038 [$66 915]) (difference, -$5773; 95% CI, -$13 682 to $2137; P = .15). Conclusions and Relevance: A compound intervention integrating wireless pill bottles, lottery-based incentives, and social support did not significantly improve medication adherence or vascular readmission outcomes for AMI survivors. Trial Registration: clinicaltrials.gov Identifier: NCT01800201.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
van Walraven, C., Austin, P. C., Jennings, A., Quan, H., & Forster, A. J. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819432e5 · Cited by 2,200
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Financial Incentive–Based Approaches for Weight Loss: A Randomized Trial
Volpp, K. G., John, L. K., Troxel, A. B., Norton, L., Fassbender, J., & Loewenstein, G. (2008) · JAMA · doi:10.1001/jama.2008.804 · Cited by 923
Self-citationA Randomized, Controlled Trial of Financial Incentives for Smoking Cessation
Volpp, K. G., Troxel, A. B., Pauly, M. V., Glick, H. A., Puig, A., Asch, D. A., Galvin, R., Zhu, J., Wan, F., DeGuzman, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0806819 · Cited by 836
Self-citationMedication adherence: a call for action
Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, S. M., Daniel, J. G., Ekman, I., Ho, M., Johnson, M., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.007 · Cited by 448
Randomized trial of four financial-incentive programs for smoking cessation
Halpern, S. D., French, B., Small, D. S., Saulsgiver, K., Harhay, M. O., Audrain-McGovern, J., Loewenstein, G., Brennan, T. A., Asch, D. A., & Volpp, K. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414293 · Cited by 379
Self-citationFinancial Incentives for Extended Weight Loss: A Randomized, Controlled Trial
John, L. K., Loewenstein, G., Troxel, A. B., Norton, L., Fassbender, J. E., & Volpp, K. G. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1628-y · Cited by 346
Self-citationA Randomized Controlled Trial of Financial Incentives for Smoking Cessation
Volpp, K. G., Gurmankin Levy, A., Asch, D. A., Berlin, J. A., Murphy, J. J., Gomez, A., Sox, H., Zhu, J., & Lerman, C. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0314 · Cited by 257
Self-citationStatin non-adherence and residual cardiovascular risk: There is need for substantial improvement
Banach, M., Stulc, T., Dent, R., & Toth, P. P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.075 · Cited by 197
Cited by
Chater, N., & Loewenstein, G. (2023) · Behavioral and Brain Sciences · doi:10.1017/s0140525x22002023 · Cited by 710
Choudhry, N. K., Kronish, I. M., Vongpatanasin, W., Ferdinand, K. C., Pavlik, V. N., Egan, B. M., Schoenthaler, A., Houston Miller, N., Hyman, D. J., & on behalf of the American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2022) · Hypertension · doi:10.1161/hyp.0000000000000203 · Cited by 349
Wearable devices in clinical trials: hype and hypothesis
Izmailova, E. S., Wagner, J. A., & Perakslis, E. D. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.966 · Cited by 265
Artificial Intelligence in Health Care: Will the Value Match the Hype?
Emanuel, E. J., & Wachter, R. M. (2019) · JAMA · doi:10.1001/jama.2019.4914 · Cited by 237
The role of psychological science in efforts to improve cardiovascular medication adherence.
Bosworth, H. B., Blalock, D. V., Hoyle, R. H., Czajkowski, S. M., & Voils, C. I. (2018) · American Psychologist · doi:10.1037/amp0000316 · Cited by 35
Metadata
- Authors
- Volpp, K. G., Troxel, A. B., Mehta, S. J., Norton, L., Zhu, J., Lim, R., Wang, W., Marcus, N., Terwiesch, C., Caldarella, K., Levin, T., Relish, M., Negin, N., Smith-McLallen, A., Snyder, R., Spettell, C. M., Drachman, B., Kolansky, D., & Asch, D. A.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2017-08-01
- Volume
- 177
- Issue
- 8
- Pages
- 1093
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2650932744
- Cited by
- 130
- References
- 11
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction: The HeartStrong Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jamainternmed.2017.2449
- The paper
- Volpp, K. G., Troxel, A. B., Mehta, S. J., Norton, L., Zhu, J., Lim, R., Wang, W., Marcus, N., Terwiesch, C., Caldarella, K., Levin, T., Relish, M., Negin, N., Smith-McLallen, A., Snyder, R., Spettell, C. M., Drachman, B., Kolansky, D., & Asch, D. A. (2017). Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction: The HeartStrong Randomized Clinical Trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2017.2449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.